Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • AstraZeneca PLC (LSE: AZN) Latest News

    Investing Articles

    Will the AstraZeneca share price be boosted by positive trial results?

    | Stepan Lavrouk

    AstraZeneca plc (LON: AZN) reports excellent data for cancer drug Lynparza. Can this help drive the share price upwards?

    Read more »

    Investing Articles

    Top shares for June 2019

    | The Motley Fool Staff

    We asked our freelance writers to share their top stock picks for the month.

    Read more »

    Investing Articles

    Is the AstraZeneca share price a FTSE 100 bargain?

    | G A Chester

    G A Chester discusses the investment case for FTSE 100 (INDEXFTSE:UKX) giant AstraZeneca plc (LON:AZN) and a small-cap pharma firm…

    Read more »

    Investing Articles

    Will AstraZeneca’s new strategy make the share price soar?

    | Stepan Lavrouk

    A pivot to cancer treatment has been profitable for AstraZeneca plc (LON:AZN), but can it last?

    Read more »

    Investing Articles

    Can the AstraZeneca share price reach 6,000p in 2019?

    | Alan Oscroft

    The AstraZeneca plc (LON: AZN) share price has been soaring, but here's why I think the bulls might be getting…

    Read more »

    Investing Articles

    Top shares for May 2019

    | The Motley Fool Staff

    We asked our freelance writers to share their top stock picks for the month.

    Read more »

    Investing Articles

    Expensive but exceptional! 2 FTSE 100 stocks I’d buy following latest news

    | Royston Wild

    These FTSE 100 (INDEXFTSE: UKX) shares might not be the cheapest. But if you're looking to make big returns, Royston…

    Read more »

    Investing Articles

    Forget the Cash ISA. Here are 2 FTSE 100 stocks I’d buy and hold forever

    | Rupert Hargreaves

    These FTSE 100 (INDEXFTSE: UKX) income champions yield nearly three times as much as the best Cash ISA on the…

    Read more »

    Investing Articles

    Should I buy GSK shares or FTSE 100 rival AstraZeneca?

    | G A Chester

    G A Chester weighs the merits of FTSE 100 (INDEXFTSE:UKX) pharmaceuticals giants GlaxoSmithKline plc (LON:GSK) and AstraZeneca plc (LON:GSK).

    Read more »

    Investing Articles

    Forget a Cash ISA! Here are 3 shares I’d buy for my Stocks and Shares ISA

    | Kevin Godbold

    I think these three are solid, dividend-paying shares capable of growth from where we are now.

    Read more »

    Investing Articles

    Got £2k to spend? 2 FTSE 100 dividend stocks I’d buy and hold for 10 years

    | Royston Wild

    Looking to invest in the new ISA year? i think these FTSE 100 (INDEXFTSE: UKX) income stocks are great ways…

    Read more »

    Investing Articles

    Forget forex trading: I think the AstraZeneca share price offers an easier way to get rich

    | Peter Stephens

    AstraZeneca plc (LON: AZN) could offer a superior risk/reward ratio than forex trading in my opinion.

    Read more »